ArticleOncotarget2020

A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy.

Nagi B Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.